-+ 0.00%
-+ 0.00%
-+ 0.00%

CURASIGHT ANNOUNCES SUCCESSFUL DOSING OF FIRST PATIENT IN PHASE 1 TRIAL WITH UTREAT® IN BRAIN CANCER

Reuters·12/18/2025 18:46:15

Please log in to view news